HRS4R
Vull donar

ROCÍO RODRÍGUEZ ROMANOS

Firma
ROCÍO RODRÍGUEZ-ROMANOS
Posició
Tècnic/a Investigador/a
Tècnics/ques investigadors/es

Projectes

Codi oficial: PI20/01353 Data inici: 01/01/2021 Data fi: 31/12/2023 Investigador/a principal: DAVID GALLARDO GIRALT Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 135,520 €

Publicacions

Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D, on the behalf of CETLAM Group

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.

Leukemia, 2020, 34, 2925-2933 dx.doi.org/10.1038/s41375-020-0784-2

Santos N, Rodríguez-Romanos R, de la Cámara R, Brunet S, Nieto JB, Buño I, Martínez C, Jiménez-Velasco A, Vallejo C, González M, Solano C, Ferrá C, Sampol A, Pérez-Simón JA, López-Jiménez J, Díez JL, Gallardo D

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.

ANNALS OF HEMATOLOGY, 2018, 97, 2217-2224 dx.doi.org/10.1007/s00277-018-3438-y

Gallardo D, Bosch-Vizcaya A, Rodríguez-Romanos R, Santos N, Buño I, de la Cámara R, Brunet S, Jiménez-Velasco A, González M, Nieto JB, Martínez-Laperche C, Vallejo C, Ferrá C, Sampol A, López-Jiménez J, Pérez-Simón JA, Martínez C, Díez JL

Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23, 2042-2047 dx.doi.org/10.1016/j.bbmt.2017.08.003

Camós S, Gubern C, Sobrado M, Rodríguez R, Romera VG, Moro MÁ, Lizasoain I, Serena J, Mallolas J, Castellanos M

Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

NEUROMOLECULAR MEDICINE, 2014, 16, 332-349 dx.doi.org/10.1007/s12017-013-8279-1

Formulari de contacte

Coneix l’IDIBGI!

menu